Sone Capital Management LLC Acquires Shares of 231,760 Definitive Healthcare Corp. (NASDAQ:DH)

Sone Capital Management LLC acquired a new position in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 231,760 shares of the company's stock, valued at approximately $953,000. Sone Capital Management LLC owned 0.20% of Definitive Healthcare at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Nisa Investment Advisors LLC increased its stake in Definitive Healthcare by 3,652.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company's stock worth $29,000 after purchasing an additional 6,794 shares during the period. Bayesian Capital Management LP purchased a new position in shares of Definitive Healthcare in the fourth quarter worth $41,000. Ieq Capital LLC purchased a new position in shares of Definitive Healthcare in the fourth quarter worth $51,000. KLP Kapitalforvaltning AS bought a new stake in Definitive Healthcare during the 4th quarter valued at $54,000. Finally, Two Sigma Securities LLC purchased a new stake in Definitive Healthcare during the 4th quarter valued at $56,000. Institutional investors own 98.67% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. The Goldman Sachs Group raised their target price on Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a research note on Monday, May 12th. BTIG Research lowered Definitive Healthcare from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th. Barclays reduced their target price on Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating on the stock in a research note on Monday, March 3rd. Finally, Wall Street Zen upgraded Definitive Healthcare from a "hold" rating to a "buy" rating in a report on Thursday. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $5.10.

Definitive Healthcare Stock Down 0.3%

Shares of DH traded down $0.01 on Thursday, reaching $3.13. The stock had a trading volume of 646,343 shares, compared to its average volume of 817,639. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. Definitive Healthcare Corp. has a 12-month low of $2.15 and a 12-month high of $6.27. The firm has a market capitalization of $465.25 million, a price-to-earnings ratio of -1.01, a price-to-earnings-growth ratio of 4.06 and a beta of 1.48. The company has a 50-day simple moving average of $2.82 and a 200-day simple moving average of $3.82.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.02 by $0.03. The firm had revenue of $59.19 million for the quarter, compared to analysts' expectations of $56.20 million. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The company's quarterly revenue was down 6.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.08 EPS. Sell-side analysts predict that Definitive Healthcare Corp. will post 0.16 EPS for the current year.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.